M2TAMs are characterized by the expression of CD68 and CD163 and are known to secrete immunosuppressive cytokines (e.g., IL-10, CCL17, CCL22) that promote angiogenesis, matrix remodeling, and tumor cell migration. This evidence concerns the gene CD68 and neoplasm.